GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
89.79
-0.50 (-0.55%)
At close: Jul 2, 2025, 4:00 PM
89.76
-0.03 (-0.03%)
After-hours: Jul 2, 2025, 7:55 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.56 billion as of July 2, 2025. Its market cap has increased by 240.53% in one year.
Market Cap
2.56B
Enterprise Value
2.52B
1-Year Change
240.53%
Ranking
Category
Stock Price
$89.79
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.56B, a decrease of -85.69%. That is a compound annual growth rate of -34.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 2.58B | 22.01% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |